From monitoring to vigilance about patient adherence to new oral anticoagulants

Europace

Volumn 16, Issue 1, 2014, Pages 149-

  Vrijens, Bernard ^a,b   Urquhart, John ^a,b,c  

^a MWV Healthcare ^*  (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ALERTNESS; AWARENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG MECHANISM; DRUG PACKAGING; FOLLOW UP; HUMAN; LETTER; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PHARMACIST; PRIORITY JOURNAL;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIOLOGY; THROMBOSIS;

EID: 84891354876     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut243     Document Type: Letter

References (5)

1. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013;15:625-51.
2. Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012;52:275-301.
3. Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 2013;73:545-62.
4. Comte L, Vrijens B, Tousset E, Gerard P, Urquhart J. Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. J Pharmacokinet Pharmacodyn 2007;34:549-58.
5. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989;46: 163-8.